Now showing items 1-1 of 1

    • Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease 

      MARTIN-CARDONA, ALBERT; Horta, D.; Florez-Diez, P.; Vela, M.; Mesonero, F.; Ramos Belinchón, C.; García, M.J.; Masnou, H.; de la Peña Negro, Luisa Carmen; SUAREZ FERRER, CRISTINA; Casanova, M.J.; Ortiz Durán, M.; Peña, E.; Calvet, X.; Fernández-Prada, S.J.; Gonzalez-Muñoza, Carlos; Piqueras, M.; Rodríguez-Lago, I.; Sainz, E.; Bas-Cutrina, Francesc; Mancediño Marcos, N.; Ojeda, A.; Orts, B.; Sicilia, B.; Castaño García, A.; Domènech, E.; Esteve, M. (Digestive and Liver Disease, 2024-03)
      Background and aims: Hepatitis C virus (HCV) management in Inflammatory Bowel Disease (IBD) is uncertain. The ECCO guidelines 2021 recommended HCV treatment but warn about the risk of IBD reactivation. ...